About: The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 2012

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2012 (fr) наукова стаття, опублікована в жовтні 2012 (uk) artículu científicu espublizáu n'ochobre de 2012 (ast) scientific article published on 01 October 2012 (en)
publication date	wds:Q84916985-611E0BF5-22C0-4ABB-BA08-7D38C34DD69E
publication date	2012-10-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q84916985-45E71E15-7948-4249-BFB2-A7772CC4BCA9
author name string	Michael Katsimpoulas
rdfs:label	The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis (en) The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis (nl)
skos:prefLabel	The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis (en) The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis (nl)
name	The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis (en) The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis (nl)
author	wds:Q84916985-00BCE670-65AA-4DFE-92A0-62AC47916256 wds:Q84916985-06F47EA1-1CB1-4A3E-A9E8-BF1956240E9A wds:Q84916985-0815EFD7-9596-4DF5-892E-77FA8A81F044 wds:Q84916985-79662FFA-3010-4F17-A0C0-36A282A6E384 wds:Q84916985-8AC8D76A-34A2-4BE5-8422-F940305E4700 wds:Q84916985-EA9481BA-0F77-4311-A9A5-842BA779E32A wds:Q84916985-FBA1EFB9-DE28-4AEB-9709-D2313E311BF8
author	Christos Liapis Alkistis Kapelouzou Katrin Schäfer Nikolaos G Kostomitsopoulos Petros Moustardas Alkiviadis Kostakis Nikolaos P E Kadoglou
title	wds:Q84916985-51E2D50A-4C67-484D-ACA7-8D566638B256
title	The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis (en)
page(s)	wds:Q84916985-8BD1A4C0-2B56-4433-A443-7CA1150CA4BD
page(s)	367-374
instance of	wds:Q84916985-2D1C9732-4FE8-441C-B204-58CFDCE1B695
instance of	scholarly article
main subject	wds:Q84916985-9370750A-FD9D-47E2-881F-F22C9EBAFA2C
main subject	dabigatran
PubMed ID	wds:Q84916985-E201BFDC-F64E-45B1-A870-2E7F1F305E45
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22940777
PubMed ID	22940777
published in	wds:Q84916985-790FAFAA-7C38-4C61-A43C-9683C5C710FB
published in	Cardiovascular Drugs and Therapy
issue	wds:Q84916985-224C6556-91E3-4FD1-B4EB-D0D9E3E4D149
volume	wds:Q84916985-74BCE0E9-4609-41F6-85F4-EEC3EEE66B6A
issue	5
volume	26
DOI	wds:Q84916985-33204C46-13E4-4629-9332-4C13ACB015C3
DOI	http://dx.doi.org/10.1007/S10557-012-6411-3
DOI	10.1007/S10557-012-6411-3
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q84916985
is cites work of	Platelets and their chemokines in atherosclerosis-clinical applications Cardiovascular outcomes during treatment with dabigatran: comprehensive analysis of individual subject data by treatment Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice Genetic and pharmacological modifications of thrombin formation in apolipoprotein e-deficient mice determine atherosclerosis severity and atherothrombosis onset in a neutrophil-dependent manner New insights into modulation of thrombin formation The discovery of dabigatran etexilate Thrombin Generation and Atherothrombosis: What Does the Evidence Indicate? Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis Long-Term Dabigatran Treatment Delays Alzheimer's Disease Pathogenesis in the TgCRND8 Mouse Model Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases Parenteral administration of factor Xa/IIa inhibitors limits experimental aortic aneurysm and atherosclerosis New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs) Administration by Gavage is the rule Dabigatran and apolipoprotein B. Intake of Vitamin K Antagonists and Worsening of Cardiac and Vascular Disease: Results From the Population-Based Gutenberg Health Study Vitamin K Antagonists, Non-Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice Effects of rivaroxaban and dabigatran on local expression of coagulation and inflammatory factors within human aortic stenotic valves
is cites work of	wds:Q30680968-CF2874D4-A535-479A-8626-C48215A3BBBB wds:Q38136548-1B86E8A1-00BF-40E8-8848-2318EBE90917 wds:Q37654883-D92B474F-4397-4134-8457-EB11503237C6 wds:Q41842059-03CF4FE4-9BB7-4672-B439-D4571C9E768C wds:Q90636107-F5F2023C-2C12-4B2D-A6C6-169F4B3EA12F wds:Q28081366-369BCC80-C8AB-42C3-AEE6-863DCBDE3303 wds:Q42636287-0050F9B1-7B76-420F-AACD-17638EDBA913 wds:Q90724393-5E088BEA-2606-4770-A50F-0AB182B8BD2F wds:Q43082536-8100A02A-52F6-47EA-91D6-F60ACB28FD3C wds:Q34019069-B3A4D968-7125-4AE8-9EBC-C55AC8981838 wds:Q41812796-489605DF-B5F6-44D3-AEDA-A6A3A0CC072C wds:Q58127461-868A16A8-D0BD-4551-9995-382B76C95E17 wds:Q35894640-490C001A-3B8B-4F68-BD7A-BE6B30FB808B wds:Q64054815-0606862B-5E94-4E1A-AF0D-4D0B022467A9 wds:Q93092252-5DFBBDD3-C4B0-4F16-BCEB-C972E03F70FD wds:Q94590506-7D68335D-730E-46C5-9B11-D6D3406DA967 wds:Q37240386-5AFEFC5B-664E-47C7-B1D7-FE079C933809 wds:Q27316270-63A1C9DB-699C-4CB2-A25A-6E8D6AB920CC

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software